What will the new year have in store for stem cells? 2016 promises to have many striking stem cell developments. Below are my top 20 stem cell predictions for what is to come this year in no particular order. Share your stem cell tea leaves in the comments please. Another stem cell biotech acquisition by pharma […]
List of 20 stem cell predictions for 2016 Read More »
It’s been a busy few weeks for the stem cell field. Below are some news briefs on developments. RetractionWatch reports that Piero Anversa is leaving Harvard/Brigham and Women’s Hospital after an investigation and dismissed lawsuit he filed against the institution. All still quiet on the STAP cell front at the same institutions. There’s some more
Stem Cell News Briefs: Anversa, Japan Regs, Ocata Suit, More Read More »
A patient in Japan has reportedly filed suit against a fat stem cell clinic and has won a judgement of 1.84 million yen in total (about $15,000 USD). The Tokyo District Court reportedly ruled in favor of the patient and most of the award is reimbursement. Authors Ikka, et al report on the case and
Patient Sues Fat Stem Cell Clinic & Wins Read More »
With these recommendations I’m aiming for a diverse range of content and perspectives, some of which I may not agree with, but all of which are interesting even if they are beyond research on medicine. Prostate Organoid from Stem Cells. More organoid news. Why Do Glowing Sharks Glow? Not exactly medicine, but a cool piece
TGIF: Recommended Science & Medicine Weekend Reads Read More »
Stem cell biotech company Bioheart ($BHRT) has had a rough 2015 so far. Could this year be a decisive, negative tipping point for the company? It has a number of clinical trials going, but from my view things seem increasingly uncertain. An oddity amongst stem cell biotechs, Bioheart and its leadership have at times seemed to toy
Bioheart on the edge in 2015? Read More »
Brigham and Women’s Hospital cardiac stem cell researcher Piero Anversa along with collaborator Annarosa Leri (pictured) are suing both the hospital and Harvard Medical School as well as leaders at the institutions over a research misconduct investigation focused on Anversa and Leri. Boston Globe reporter Carolyn Johnson has been covering Anversa and for background on this new
Harvard Sued by Anversa Over Stem Cell Paper Misconduct Investigation Read More »
Every year I look into my stem cell crystal ball and make a top 10 list of stem cell predictions for the coming year. My predictions for 2015 will be coming up soon and I may bump them up to 20 predictions instead of 10 because there’s so much going on in the field. Stay
Stem cell crystal ball: how did my 2014 predictions fare? Read More »
StemCells Inc. is a top biotech company developing stem cell-based therapies. They have a deep pipeline that includes already ongoing trials for a variety of diseases. I invited company leadership to do an interview and they graciously accepted. Below is the interview with CFO Greg Schiffman (picture at left from LinkedIn) including what I thought
Interview with StemCells Inc. leadership on hot topics Read More »
Who is trying, via the name BioGatekeeper, Inc., to nullify Yamanaka’s patent on cellular reprogramming to produce induced pluripotent stem (iPS) cells? The readers of this blog never cease to amaze me. What an informed, energetic, bright group. Within just days they may have collectively shed some light on an intriguing mystery in the stem cell field surrounding the
Blog readers investigate BioGatekeeper, the Yamanaka patent challenger Read More »
Clare Wilson over at the NewScientist has reported the case of a woman given an experimental stem cell treatment in Portugal for a spinal cord injury who later developed a strange tumor consisting of nose tissue. I highly recommend going over to that site and reading her excellent article. What’s the deal with this case? The woman was
Woman grows nose tumor in spine after stem cell injection Read More »